Home
About
Overview
Sharing Data
ORCID
Help
History (4)
ACR Appropriateness Criteria on percutaneous catheter drainage of infected fluid collections.
Computer-aided diagnosis in chest radiology.
Cutting Edge: Engineering Active IKKß in T Cells Drives Tumor Rejection.
The effects of 17ß-estradiol and a selective estrogen receptor modulator, bazedoxifene, on ovarian carcinogenesis.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Cutting Edge: Engineering Active IKKß in T Cells Drives Tumor Rejection.
Cutting Edge: Engineering Active IKKß in T Cells Drives Tumor Rejection. J Immunol. 2016 Apr 01; 196(7):2933-8.
View in:
PubMed
subject areas
Adoptive Transfer
Animals
CD8-Positive T-Lymphocytes
Cell Line, Tumor
Cytotoxicity, Immunologic
Disease Models, Animal
Gene Expression
Genetic Engineering
Heterografts
Humans
I-kappa B Kinase
Interferon-gamma
Lymphocyte Count
Lymphocytes, Tumor-Infiltrating
Mice
Mice, Transgenic
Neoplasms
NF-kappa B
Signal Transduction
T-Lymphocytes
Tumor Burden
authors with profiles
Luciana Molinero
Maria-Luisa Alegre
Thomas F. Gajewski